Sigyn Therapeutics, Inc.
SIGY
$4.10
-$0.0099-0.24%
SIGY market cap represents
0.00%
of the industry.
Valuation
SIGY
Low
SIGY
Industry Average
High
Market Cap
6.58M
< 6.58M
> 20.81B
Enterprise Value
8.39M
< 0.00
> 25.15B
Price/Earnings (TTM)
-1.27
< -10.00
> 30.00
Earnings Per Share Growth (TTM)
-14.93%
< -20.00%
> 220.00%
Price/Earnings To Growth (TTM)
--
0.01
9.48
Price/Sales (TTM)
--
-0.633
713.158
Price/Book (Q)
-1.48
< -10.00
> 20.00
Enterprise Value/Revenue (TTM)
--
-15.87
659.39
Enterprise Value/EBITDA (TTM)
-3.05
< -70.00
> 0.00
Enterprise Value/EBIT (TTM)
-3.04
< -10.00
> 10.00
Dividends and Shares
SIGY
Low
SIGY
Industry Average
High
Shares Outstanding
1.27M
18.00K
> 240.00M
Dividend Per Share (Most Recent)
--
0.03
2.10
Dividend Per Share (TTM)
--
0.06
8.40
Dividend Yield (TTM)
--
0.15%
7.81%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
SIGY
Low
SIGY
Industry Average
High
Beta
0.11
< 0.00
7.08
1-Month Total Return
28.12%
< -30.00%
> 30.00%
3-Month Total Return
0.74%
< -10.00%
> 10.00%
6-Month Total Return
-28.70%
< -30.00%
> 30.00%
Year to Date Total Return
30.16%
< -10.00%
> 40.00%
1-Year Total Return
-18.00%
< -20.00%
> 30.00%
2-Year Total Return
-34.29%
< -40.00%
> 50.00%
3-Year Total Return
-77.72%
< -80.00%
> 0.00%
5-Year Total Return
--
-100.00%
17,571.67%
Profitability
SIGY
Low
SIGY
Industry Average
High
Operating Margin (TTM)
--
-100,570.96%
423.48%
Profit Margin (TTM)
--
-73,864.51%
480.40%
Management Effectiveness
SIGY
Low
SIGY
Industry Average
High
Return on Assets (TTM)
-423.29%
-293.03%
> 0.00%
Return on Equity (TTM)
--
0.36%
824.40%
Income Statement
SIGY
Low
SIGY
Industry Average
High
Revenue (TTM)
--
-4.27M
370.66B
Total Revenue (TTM)
--
-4.27M
400.28B
Total Revenue Growth (Q YOY)
--
-98.51%
137,800.00%
Revenue Per Share (TTM)
--
-8.53
3,202.33
Gross Profit (TTM)
--
-6.05M
89.40B
EBITDA (TTM)
-2.75M
< -10.00M
> 1.74B
EBIT (TTM)
-2.76M
< -10.00M
> 1.27B
Net Income (TTM)
-3.99M
< -10.00M
> 670.00M
Net Income Avl. to Common (TTM)
-3.99M
< -10.00M
> 670.00M
Earnings Growth (Q YOY)
-32.15%
< -790.00%
> -30.00%
EPS Diluted (TTM)
-3.23
< -20.00
> 0.00
EPS Diluted Growth (Q YOY)
-15.05%
< -310.00%
> -10.00%
Balance Sheet
SIGY
Low
SIGY
Industry Average
High
Cash and Short-Term Inv. (Q)
164.80K
45.00K
> 1.82B
Cash Per Share (Q)
0.13
0.01
> 30.00
Total Current Assets (Q)
269.10K
18.60K
> 6.02B
Total Assets (Q)
427.40K
941.70K
> 16.94B
Total Current Liabilities (Q)
4.28M
110.30K
> 5.26B
Total Debt (Q)
1.98M
0.00
> 5.13B
Total Liabilities (Q)
4.35M
299.40K
> 11.05B
Total Common Equity (Q)
-3.92M
< -10.00M
> 5.64B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
-3.92M
< -10.00M
> 5.89B
Current Ratio (Q)
0.063
0.009
> 10.000
Book Value Per Share (Q)
-2.76
< -10.00
> 20.00
Cash Flow
SIGY
Low
SIGY
Industry Average
High
Cash from Operations (TTM)
-710.10K
< -10.00M
> 1.12B
Cash from Investing (TTM)
--
-20.53B
3.43B
Cash from Financing (TTM)
810.40K
< -350.00M
> 10.00M
Net Change in Cash (TTM)
100.10K
< 0.00
> 20.00M
Levered Free Cash Flow (TTM)
600.00K
< 0.00
> 670.00M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
